You just read:

Medicenna To Host Key Opinion Leader Call Focused on MDNA55 Recurrent Glioblastoma Program and Preliminary Top-Line Results

News provided by

Medicenna Therapeutics Corp.

Jun 13, 2019, 07:30 ET